VITA — Vitaminka AD Prilep Cashflow Statement
0.000.00%
- MKD876.20m
- MKD2.53bn
- MKD3.50bn
- 32
- 92
- 67
- 74
Annual cashflow statement for Vitaminka AD Prilep, fiscal year end - December 31st, MKD millions except per share, conversion factor applied.
2020 December 31st | 2021 December 31st | 2022 December 31st | R2023 December 31st | 2024 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | ARS | ARS | ARS | ARS | ARS |
Standards: | IFRS | IFRS | — | IFRS | IFRS |
Status: | Final | Final | Final | Final | Final |
Net Income/Starting Line | 29.3 | 83.2 | 75.3 | 109 | 100 |
Depreciation | |||||
Non-Cash Items | 8.65 | -22.9 | -73.9 | 16.6 | -4.58 |
Unusual Items | |||||
Other Non-Cash Items | |||||
Changes in Working Capital | -167 | -255 | -100 | 10.4 | -89.4 |
Change in Accounts Receivable | |||||
Change in Inventories | |||||
Change in Payable / Accrued Expenses | |||||
Other Operating Cash Flow | |||||
Cash from Operating Activities | -13.7 | -72.3 | 28.5 | 274 | 153 |
Capital Expenditures | -105 | -187 | -247 | -109 | -189 |
Purchase of Fixed Assets | |||||
Purchase / Acquisition of Intangibles | |||||
Other Investing Cash Flow Items | 2.31 | 48.4 | 88 | -51.6 | -0.408 |
Sale of Fixed Assets | |||||
Sale/Maturity of Investment | |||||
Purchase of Investments | |||||
Other Investing Cash Flow | |||||
Cash from Investing Activities | -103 | -138 | -159 | -161 | -189 |
Financing Cash Flow Items | — | — | 27.5 | 34.8 | 2.06 |
Other Financing Cash Flow | |||||
Total Cash Dividends Paid | |||||
Net Issuance / Retirement of Stock | |||||
Net Issuance / Retirement of Debt | |||||
Cash from Financing Activities | 136 | 193 | 125 | -103 | 49 |
Beginning Cash Balance | |||||
Ending Cash Balance | |||||
Net Change in Cash | 18.9 | -17.3 | -5.54 | 9.47 | 13.3 |